MEP90908A - Solid lipid formulati on - Google Patents

Solid lipid formulati on

Info

Publication number
MEP90908A
MEP90908A MEP-909/08A MEP90908A MEP90908A ME P90908 A MEP90908 A ME P90908A ME P90908 A MEP90908 A ME P90908A ME P90908 A MEP90908 A ME P90908A
Authority
ME
Montenegro
Prior art keywords
formulati
solid lipid
fatty acid
acid ester
smiles
Prior art date
Application number
MEP-909/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Smidt Passchier Christiaan De
Paul Hadvary
Hans Lengsfeld
Marcel Schmid
David Macfarland Small
Hans Steffen
Joseph Tardio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238989&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP90908(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of MEP90908A publication Critical patent/MEP90908A/xx
Publication of ME00675B publication Critical patent/ME00675B/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
MEP-2008-909A 1999-09-13 2000-09-11 Formulations lipidiques solides ME00675B (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99118179 1999-09-13
PCT/EP2000/008857 WO2001019378A2 (fr) 1999-09-13 2000-09-11 Formulations lipidiques solides

Publications (2)

Publication Number Publication Date
MEP90908A true MEP90908A (en) 2011-12-20
ME00675B ME00675B (fr) 2011-12-20

Family

ID=8238989

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-909A ME00675B (fr) 1999-09-13 2000-09-11 Formulations lipidiques solides

Country Status (36)

Country Link
US (1) US6703369B1 (fr)
EP (1) EP1216048B1 (fr)
JP (1) JP4217017B2 (fr)
KR (1) KR100523879B1 (fr)
CN (1) CN1197554C (fr)
AR (1) AR025609A1 (fr)
AT (1) ATE285783T1 (fr)
AU (1) AU769016B2 (fr)
BR (1) BRPI0013940B1 (fr)
CA (1) CA2383036C (fr)
CO (1) CO5210857A1 (fr)
CZ (1) CZ301844B6 (fr)
DE (1) DE60017156T2 (fr)
EG (1) EG24225A (fr)
ES (1) ES2233444T3 (fr)
GC (1) GC0000259A (fr)
HK (1) HK1049798B (fr)
HR (1) HRP20020206B1 (fr)
HU (1) HU229037B1 (fr)
IL (2) IL148570A0 (fr)
JO (1) JO2300B1 (fr)
MA (1) MA26817A1 (fr)
ME (1) ME00675B (fr)
MX (1) MXPA02002662A (fr)
MY (1) MY127430A (fr)
NO (1) NO328889B1 (fr)
NZ (1) NZ517396A (fr)
PE (1) PE20010661A1 (fr)
PL (1) PL199869B1 (fr)
PT (1) PT1216048E (fr)
RS (1) RS50373B (fr)
RU (1) RU2248218C2 (fr)
SI (1) SI1216048T1 (fr)
TR (1) TR200200605T2 (fr)
WO (1) WO2001019378A2 (fr)
ZA (1) ZA200201249B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR025609A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
CN100423715C (zh) * 2000-07-28 2008-10-08 霍夫曼-拉罗奇有限公司 新型药物组合物
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US6730319B2 (en) * 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
DE10251963A1 (de) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Transmucosale pharmazeutische Darreichungsform
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
WO2004078164A1 (fr) * 2003-03-04 2004-09-16 Nostrum Pharmaceuticals, Inc. Formulation a liberation commandee renfermant une substance hydrophobe comme agent de liberation soutenue
FI20045076L (fi) * 2004-03-15 2005-09-16 Bioferme Oy Funktionaalinen elintarvike
BRPI0516772A (pt) * 2004-10-25 2008-09-23 Japan Tobacco Inc formulação sólida com solubilidade e estabilidade melhoradas e método para produção da referida formulação
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
US20070148245A1 (en) * 2005-12-22 2007-06-28 Ilan Zalit Compressed solid dosage forms with drugs of low solubility and process for making the same
WO2007073389A1 (fr) * 2005-12-22 2007-06-28 Teva Pharmaceutical Industries Ltd. Formes de dosage solides comprimées comprenant des médicaments de faible solubilité et procédé servant à les fabriquer
EP1808163A1 (fr) * 2005-12-22 2007-07-18 Teva Pharmaceutical Industries Ltd. Formes galéniques solides comprimées avec des principes actifs de faible solubilité et leur procédé de fabrication
KR101252635B1 (ko) 2006-04-20 2013-04-10 (주)아모레퍼시픽 리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
KR100903504B1 (ko) * 2007-05-18 2009-06-17 강태용 비라칸사스 열매 추출물질을 포함하는 기능식품 및 체중 감소제
JP2010536798A (ja) * 2007-08-17 2010-12-02 テバ ファーマシューティカル インダストリーズ リミティド 難溶性薬物の生体利用率を制御するための方法及び組成物
ES2350798T3 (es) * 2007-09-12 2011-01-27 Mader S.R.L. Composiciones farmacéuticas para uso oral para tratar a pacientes afectados por la obesidad.
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
WO2010042499A1 (fr) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Solutions stables d'orlistat pour formes galéniques pharmaceutiques
BRPI0901602B8 (pt) 2009-04-03 2021-05-25 Ems S/A formulação farmacêuticas
UA107369C2 (en) 2010-02-01 2014-12-25 Lab Bago S A Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
EP2486805A1 (fr) * 2011-02-11 2012-08-15 Puratos N.V. Émulsion à fouettement à température ambiante
WO2012140937A1 (fr) * 2011-04-14 2012-10-18 株式会社Ｊ－オイルミルズ Huile de palme fractionnée, composition d'huile et produit alimentaire la contenant
CN102552168B (zh) * 2012-01-31 2013-08-07 杭州华东医药集团生物工程研究所有限公司 一种含有奥利司他的药物组合物及其制备方法
GB2501535A (en) 2012-04-26 2013-10-30 Sony Corp Chrominance Processing in High Efficiency Video Codecs
EP2854763B1 (fr) * 2012-05-31 2018-09-26 Repros Therapeutics Inc. Formulations d'administration vaginale d'antiprogestines
WO2015063039A1 (fr) 2013-10-28 2015-05-07 Nestec S.A. Monoacylglycérols destinés à être utilisés conjointement avec un inhibiteur de lipases et/ou des régimes faibles en matières grasses et/ou calories
CN115105476B (zh) * 2021-03-23 2023-11-14 山东新时代药业有限公司 一种奥利司他冻干口服制剂及其制备工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (fr) * 1983-06-22 1988-12-28 Paul Hadvary Derives de leucine
FR2710264B1 (fr) * 1993-09-21 1995-12-08 Rocher Yves Biolog Vegetale Utilisation pour le traitement des peaux mixtes d'une quantité efficace de substances actives.
AU5185398A (en) * 1996-12-04 1998-06-29 James S Pincott Process and apparatus for making crumb rubber from scrap tyres
BR9807655A (pt) 1997-02-05 2000-02-15 Hoffmann La Roche Uso de inibidores de lipase gastrintestinal.
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
BR9912980B1 (pt) 1998-08-14 2013-10-22 Composição farmacêutica administrável oralmente, tablete de mascar contendo a mesma e utilização da mesma
DE69916288T2 (de) * 1998-08-14 2005-03-24 F. Hoffmann-La Roche Ag Lipasehemmer und chitosan enthaltende arzneimittel
AR025609A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas

Also Published As

Publication number Publication date
KR100523879B1 (ko) 2005-10-26
TR200200605T2 (tr) 2002-08-21
JO2300B1 (en) 2005-09-12
RS50373B (sr) 2009-11-10
ES2233444T3 (es) 2005-06-16
ATE285783T1 (de) 2005-01-15
HU229037B1 (en) 2013-07-29
CN1373659A (zh) 2002-10-09
AR025609A1 (es) 2002-12-04
PE20010661A1 (es) 2001-06-25
JP4217017B2 (ja) 2009-01-28
HUP0202762A2 (hu) 2003-01-28
BR0013940A (pt) 2002-05-14
KR20020060177A (ko) 2002-07-16
CO5210857A1 (es) 2002-10-30
GC0000259A (en) 2006-11-01
CN1197554C (zh) 2005-04-20
IL148570A (en) 2007-03-08
MXPA02002662A (es) 2002-07-30
PT1216048E (pt) 2005-04-29
HRP20020206B1 (en) 2011-02-28
AU7517700A (en) 2001-04-17
HK1049798B (zh) 2005-08-05
WO2001019378A2 (fr) 2001-03-22
MY127430A (en) 2006-11-30
RU2248218C2 (ru) 2005-03-20
CA2383036A1 (fr) 2001-03-22
AU769016B2 (en) 2004-01-15
DE60017156T2 (de) 2006-01-05
CA2383036C (fr) 2006-01-10
HK1049798A1 (en) 2003-05-30
EG24225A (en) 2008-11-10
MA26817A1 (fr) 2004-12-20
HUP0202762A3 (en) 2005-04-28
NZ517396A (en) 2003-10-31
IL148570A0 (en) 2002-09-12
WO2001019378A3 (fr) 2001-05-10
NO328889B1 (no) 2010-06-07
US6703369B1 (en) 2004-03-09
CZ20021277A3 (cs) 2003-04-16
EP1216048A2 (fr) 2002-06-26
PL356154A1 (en) 2004-06-14
DE60017156D1 (de) 2005-02-03
NO20021205L (no) 2002-03-12
BRPI0013940B1 (pt) 2016-06-21
RU2002107450A (ru) 2004-01-10
YU13602A (sh) 2006-01-16
SI1216048T1 (en) 2005-06-30
PL199869B1 (pl) 2008-11-28
CZ301844B6 (cs) 2010-07-07
JP2003509373A (ja) 2003-03-11
EP1216048B1 (fr) 2004-12-29
HRP20020206A2 (en) 2004-04-30
ZA200201249B (en) 2003-07-30
NO20021205D0 (no) 2002-03-12
ME00675B (fr) 2011-12-20

Similar Documents

Publication Publication Date Title
AR025609A1 (es) Formulaciones lipidas solidas
DK1313510T3 (da) Injicerbar farmaceutisk sammensætning til systemisk administration af farmakologisk aktive aktivstoffer indeholdende middelkædede triglycerider
ITPD980298A0 (it) Composizioni iniettabili, biocompatibili e biodegradabili comprendenti almeno un derivato dell'acido ialuronico, cellule condrogeniche, per
IT8920170A0 (it) Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
HUP0101653A3 (en) Fatty acid derivatives of bile acids and bile acid derivatives and pharmaceutical compositions thereof
WO2007101005A3 (fr) Compositions et méthodes pour pratiquer un détachement vitreux postérieur contrôlé
DK1203766T3 (da) Carboxylisyrederivater, der hæmmer bindingen af integriner til deres receptorer
ATE215969T1 (de) Thermoplastisch verarbeitbare stärke bzw. stärkederivat-polymermischungen
DK1176956T3 (da) Carboxylsyrederivater, som inhiberer bindingen af integriner til deres receptorer
MX9306133A (es) Composicion que comprende una formulacion del factor de coagulacion viii, proceso para su preparacion y uso de un surfactante como estabilizador.
DK0968719T3 (da) Enzymsammensætning, der er i stand til at danne et oligosaccharid in vivo
DE60135980D1 (de) Vergiessbare backfettzusammensetzung
IT8722343A0 (it) Derivati di acidi biliari loro preparazione e composizioni farmaceutiche che li contengono.
KR950010875A (ko) 피부외용제
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
DE69323238D1 (de) Kalorienarmer Kakaobutterersatz
DE60014369D1 (de) Propansäurederivate, die die bindung von integrinen an ihre rezeptoren behindern
HRP20020804B1 (en) Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients
IT8920169A0 (it) Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
DK1699297T3 (da) Væskefyldte tyggegummi sammensætninger
NO20014341D0 (no) Opplösning av flerumettede fettsyrer og derivater derav ved dannelse av inklusjonssammensetninger med <gamma>-syklodekstrin ogbruk derav i farmasöytiske, kosmetiske eller matsammensetninger
IT8424187A0 (it) Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
GB2349336B (en) Pesticidal composition based on 2-methoxycarbonyl-4-chlorotrifluoromethanesulphonanilide & an ester of an alkanedicarboxylic, citric or fatty acid
ECSP003653A (es) Formulaciones solidas de lipido
NO20006197D0 (no) Anvendelse av minst én syre av sitronsyrecyklusen i kombinasjon med glycerol som et insektsbekjempende middel